Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 40

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 40
---
 above, sole dispositive power with respect to 10,969,187 of the shares indicated above and shared dispositive power with respect to 141,209 of the shares indicated above. |

| (2) | Based on a Schedule 13G/A filed with the SEC on February 2, 2024 by BlackRock, Inc., on behalf of itself and its named subsidiaries and affiliates (collectively, “BlackRock”), as of December 31, 2023. BlackRock reported sole voting power with respect to 10,528,387 of the shares indicated above and sole dispositive power with respect to all of the shares indicated above. |

| (3) | Based on a Schedule 13G filed with the SEC on November 12, 2024 by FMR LLC, along with certain of its subsidiaries and affiliates, and other companies (collectively, “FMR”), as of September 30, 2024. FMR reported sole voting power with respect to 7,663,206 of the shares indicated above and sole dispositive power with respect to all of the shares indicated above. Abigail P. Johnson is a Director, the Chairman, and the Chief Executive Officer of FMR. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR, representing 49% of the voting power of FMR. The Johnson family group and all other Series B shareholders have entered into a shareholders’ voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders’ voting agreement, members of the Johnson family may be deemed to form a controlling group with respect to FMR. |

| (4) | Based on a Schedule 13G filed with the SEC on November 14, 2024 by T. Rowe Price Associates, Inc. (T. Rowe Price), as of September 30, 2024. T. Rowe Price reported sole voting power with respect to 7,277,100 of the shares indicated above and sole dispositive power with respect to all of the shares indicated above. |

| (5) | Based on a Schedule 13G filed with the SEC on February 9, 2024 by Invesco Ltd. (Invesco), as of December 29, 2023. Invesco, together